Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Celiprolol and the heart.

S H Taylor1

  • 1Department of Medical Cardiology, General Infirmary, Leeds, England.

The American Journal of Cardiology
|February 10, 1988
PubMed
Summary
This summary is machine-generated.

Celiprolol, a beta-blocker, preserves left ventricular function unlike other agents. It offers anti-ischemic benefits and a favorable lipid profile for hypertension and coronary artery disease management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Maximal stomatal conductance to water and plasticity in stomatal traits differ between native and invasive introduced lineages of Phragmites australis in North America.

AoB PLANTS·2016
Same author

Photosynthetic pathway and ecological adaptation explain stomatal trait diversity amongst grasses.

The New phytologist·2011
Same author

Drought limitation of photosynthesis differs between C₃and C₄grass species in a comparative experiment.

Plant, cell & environment·2010
Same author

Effects of chronic hepatitis C infection on the treatment of breast cancer patients.

Annals of oncology : official journal of the European Society for Medical Oncology·2009
Same author

Efficacy and tolerability of amlodipine in the general practice treatment of essential hypertension in an asian multinational population.

Clinical drug investigation·2008
Same author

Social work practice with people with disabilities in the era of disability rights.

Social work in health care·2001
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Beta-adrenoceptor antagonists are crucial for hypertension and coronary artery disease.
  • Nonselective beta blockade has circulatory drawbacks, driving the search for ideal drugs.
  • Celiprolol's cardiodynamic profile requires evaluation for optimal therapeutic use.

Purpose of the Study:

  • To evaluate celiprolol's effects on cardiac function, particularly left ventricular function.
  • To compare celiprolol's effects with other beta-blockers in normal and hypertensive hearts.
  • To assess celiprolol's efficacy in patients with coronary artery disease and hypertension.

Main Methods:

  • Investigated celiprolol's impact on left ventricular pumping function at rest and during exercise.
  • Compared celiprolol's effects to propranolol and other beta-adrenoceptor antagonists.

Related Experiment Videos

  • Assessed celiprolol's anti-ischemic properties and effects on lipid profiles.

    • Main Results:

    • Celiprolol does not depress left ventricular pumping function in normal hearts, unlike propranolol.
    • Celiprolol maintains left ventricular function at rest and during exercise.
    • Celiprolol exhibits anti-ischemic properties comparable to atenolol and a less atherogenic lipid profile than some cardioselective beta-blockers.

    Conclusions:

    • Celiprolol offers a desirable cardiodynamic profile, preserving left ventricular function.
    • Celiprolol is a potential therapeutic option for hypertension and coronary artery disease.
    • Celiprolol demonstrates anti-ischemic effects and a favorable lipid profile, distinguishing it from other beta-blockers.